Home » Topics » BioWorld Science

BioWorld Science
RSS

Esperion's third pivotal study of bempedoic acid meets primary endpoint

May 24, 2018

DSMB recommends continuation of phase II study of Xanamem in Alzheimer's disease

May 24, 2018

Clinical results reported for bifunctional short-hairpin RNA for Ewing's sarcoma

May 24, 2018

Targeting TGF-beta-1 prevents pulmonary fibrosis in rats

May 24, 2018

FDA approves Yonsa for metastatic CRPC

May 24, 2018

PanOptica initiates phase I/II trial of PAN-90806 in wet AMD

May 24, 2018

Plant Advanced Technologies patents quinic acid derivatives

May 24, 2018

Center for Translational Drug Development synthesizes ROCK1/2 inhibitors

May 24, 2018

Hefei Co-Source Pharmaceuticals and Anhui Blooming Drug Safety Evaluation patent steroids

May 24, 2018

RARI-049, a novel Nampt inhibitor for treating pulmonary hypertension

May 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...